CIBA Vision Corporation, the eye care unit of Novartis AG has completed the merger of WJ Acquisition Corp., an indirect wholly owned subsidiary of Novartis, with and into Wesley Jessen VisionCare, Inc. Wesley Jessen is now an indirect wholly owned subsidiary of Novartis. The acquisition of Wesley Jessen is an important move for CIBA Vision Read more about Ciba Vision Completes Acquisition Of Wesley Jessen[…]
Spectrum Pharmaceuticals, Inc. and FDC Ltd. announced the signing of a marketing and supply agreement under which FDC will develop and manufacture generic drug products in India, and Spectrum will pursue the regulatory approval, marketing and distribution of the approved drugs for sale in the United States. Nandan Chandavarkar, Executive Director of FDC Ltd., commented, Read more about Spectrum Pharmaceuticals And FDC Enter Into Generic Agreement[…]
EntreMed, Inc. has announced the execution of an agreement granting Oxford BioMedica plc exclusive worldwide rights to develop the localized delivery of two gene targets from EntreMed as a possible treatment for the loss of vision. Neil Campbell, EntreMed President and Chief Operating Officer, commented, “Given Oxford BioMedica’s gene therapy expertise, we are pleased that Read more about Licensing Deal For EntreMed And Oxford BioMedica[…]